WPG Advisers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4K Buy
161
+33
+26% +$3.38K 0.01% 629
2026
Q1
$14K Buy
128
+8
+7% +$763 0.01% 574
2025
Q4
$9.73K Sell
120
-23
-16% -$1.98K 0.01% 708
2025
Q3
$12.5K Hold
143
– – 0.01% 635
2025
Q2
$11.9K Buy
143
+64
+81% +$5.35K 0.01% 612
2025
Q1
$6.63K Sell
79
-121
-61% -$11.3K 0.01% 781
2024
Q4
$18.4K Buy
+200
New +$19.2K 0.02% 478

Other funds holding LMAT

WPG Advisers's LMAT Position: Q2 2026 in Review

WPG Advisers increased its LeMaitre Vascular (LMAT) stake by 26% in Q2 2026, buying an estimated $3.38K and bringing the position to 161 shares worth $15.4K. The position accounts for 0.01% of the portfolio, ranked #629.

WPG Advisers first reported a position in LMAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.4K in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • WPG Advisers held 161 shares of LeMaitre Vascular worth $15.4K as of Q2 2026.
  • WPG Advisers bought 33 LeMaitre Vascular shares in Q2 2026, an estimated $3.38K.
  • LeMaitre Vascular made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #629 holding.
  • WPG Advisers first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's LeMaitre Vascular position peaked at $18.4K in Q4 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.